Scientific, academic and artistic work
A selection of recent journal publications, artistic productions, books, including book and report excerpts.
See all publications in the database
Journal publications
-
Håland, Erling;
Moen, Ingrid Nyhus;
Veidal, Elias;
Hella, Hanne;
Misund, Kristine;
Slørdahl, Tobias Schmidt;
Starheim, Kristian K..
(2021)
TAK1-inhibitors are cytotoxic for multiple myeloma cells alone and in combination with melphalan.
OncoTarget.
vol. 12 (21).
-
Olsen, Oddrun Elise;
Hella, Hanne;
Elsaadi, Samah;
Jacobi, Carsten;
Martinez-Hackert, Erik;
Holien, Toril.
(2020)
Activins as Dual Specificity TGF-β Family Molecules: SMAD-Activation via Activin- and BMP-Type 1 Receptors.
Biomolecules.
vol. 10 (4).
-
Westhrin, Marita;
Holien, Toril;
Zahoor, Muhammad;
Moen, Siv Helen;
Buene, Glenn;
Størdal, Berit Fladvad;
Hella, Hanne;
Yuan, Huipin;
de Bruijn, Joost D;
Martens, Anton;
Groen, Richard WJ;
Bosch, Fátima;
Smith, Ulf;
Sponaas, Anne-Marit;
Sundan, Anders;
Standal, Therese.
(2020)
Bone Morphogenetic Protein 4 Gene Therapy in Mice Inhibits Myeloma Tumor Growth, But Has a Negative Impact on Bone.
JBMR Plus.
vol. 4 (1).
-
Holien, Toril;
Westhrin, Marita;
Moen, Siv Helen;
Zahoor, Muhammad;
Buene, Glenn;
Størdal, Berit Fladvad;
Hella, Hanne;
Yuan, Huipin;
de Bruijn, Joost D;
Martens, Anton;
Groen, Richard WJ;
Bosch, Fátima;
Smith, Ulf;
Sundan, Anders;
Standal, Therese.
(2018)
BMP4 Gene Therapy Inhibits Myeloma Tumor Growth, but Has a Negative Impact on Bone.
Blood.
vol. 132.
-
Olsen, Oddrun Elise;
Sankar, Meenu;
Elsaadi, Samah;
Hella, Hanne;
Buene, Glenn;
Darvekar, Sagar;
Misund, Kristine;
Katagiri, Takenobu;
Knaus, Petra;
Holien, Toril.
(2018)
BMPR2 inhibits activin and BMP signaling via wild-type ALK2.
Journal of Cell Science.
vol. 131 (11).
-
Moen, Siv Helen;
Westhrin, Marita;
Zahoor, Muhammad;
Nørgaard, Nikolai Nordberg;
Hella, Hanne;
Størdal, Berit Fladvad;
Sundan, Anders;
Nilsen, Nadra J.;
Sponaas, Anne-Marit;
Standal, Therese.
(2016)
Caspase-8 regulates the expression of pro- and anti-inflammatory cytokines in human bone marrow-derived mesenchymal stromal cells.
Immunity,Inflammation and Disease.
vol. 4 (3).
-
Starheim, Kristian Kobbenes;
Holien, Toril;
Misund, Kristine;
Johansson, Ida;
Baranowska, Katarzyna Anna;
Sponaas, Anne Marit;
Hella, Hanne;
Buene, Glenn;
Waage, Anders;
Sundan, Anders;
Bjørkøy, Geir.
(2016)
Intracellular glutathione determines bortezomib cytotoxicity in multiple myeloma cells.
Blood Cancer Journal.
-
Olsen, Oddrun Elise;
Wader, Karin Fahl;
Hella, Hanne;
Mylin, Anne K.;
Turesson, Ingemar;
Nesthus, Ingerid;
Waage, Anders;
Sundan, Anders;
Holien, Toril.
(2015)
Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B.
Cell Communication and Signaling.
vol. 13:27.
-
Holien, Toril;
Olsen, Oddrun Elise;
Misund, Kristine;
Hella, Hanne;
Waage, Anders;
Rø, Torstein Baade;
Sundan, Anders.
(2013)
Lymphoma and myeloma cells are highly sensitive to growth arrest and apoptosis induced by artesunate.
European Journal of Haematology.
vol. 91 (4).
-
Holien, Toril;
Våtsveen, Thea Kristin;
Hella, Hanne;
Waage, Anders;
Sundan, Anders.
(2013)
Dependency on c-MYC in multiple myeloma.
Cancer Research.
vol. 73 (8).
-
Holien, Toril;
Våtsveen, Thea Kristin;
Hella, Hanne;
Rampa, Christoph Samuel;
Brede, Gaute;
Grøseth, Lill Anny Gunnes;
Rekvig, Magne;
Børset, Magne;
Standal, Therese;
Waage, Anders;
Sundan, Anders.
(2012)
Bone morphogenetic proteins induce apoptosis in multiple myeloma cells by Smad-dependent repression of MYC.
Leukemia.
vol. 26.
-
Holien, Toril;
Våtsveen, Thea Kristin;
Hella, Hanne;
Waage, Anders;
Sundan, Anders.
(2012)
Addiction to c-MYC in multiple myeloma.
Blood.
vol. 120 (12).
-
Holien, Toril;
Våtsveen, Thea Kristin;
Hella, Hanne;
Rampa, Christoph Samuel;
Brede, Gaute;
Grøseth, Lill Anny Gunnes;
Rekvig, Magne;
Børset, Magne;
Standal, Therese;
Waage, Anders;
Sundan, Anders.
(2011)
BONE MORPHOGENETIC PROTEINS INDUCE APOPTOSIS BY SMAD-DEPENDENT DOWNREGULATION OF MYC.
Haematologica.
vol. 96.
-
Nørgaard, Nikolai Nordberg;
Holien, Toril;
Jönsson, S;
Hella, Hanne;
Espevik, Terje;
Sundan, Anders;
Standal, Therese.
(2011)
CpG-ODN inhibits Smad-dependent BMP signaling; Effects on myeloma cell apoptosis and in vitro osteoblastogenesis.
Bone.
vol. 48 (1).
-
Nørgaard, Nikolai Nordberg;
Holien, Toril;
Jonsson, Sofia;
Hella, Hanne;
Espevik, Terje;
Sundan, Anders;
Standal, Therese.
(2010)
CpG-Oligodeoxynucleotide Inhibits Smad-Dependent Bone Morphogenetic Protein Signaling: Effects on Myeloma Cell Apoptosis and In Vitro Osteoblastogenesis.
Journal of Immunology.
vol. 185 (6).
-
Brenne, Anne-Tove;
Fagerli, Unn Merete;
Shaughnessy, JD;
Våtsveen, Thea Kristin;
Rø, Torstein Baade;
Hella, Hanne;
Zhan, Fenghuang;
Barlogie, Bart;
Sundan, Anders;
Børset, Magne;
Waage, Anders.
(2009)
High expression of BCL3 in human myeloma cells is associated with increased proliferation and inferior prognosis.
European Journal of Haematology.
vol. 82 (5).
-
Lamvik, Jon;
Hella, Hanne;
Liabakk, Nina-Beate;
Halaas, Øyvind.
(2001)
Nonlabeled Secondary Antibodies Augment/Maintain the binding of Primarym Specific Antibodies to Cell Membrane Antigens.
Cytometry.
vol. 45.
Report/dissertation
-
Hella, Hanne;
Krøkje, Åse.
(2007)
Fremstilling av monoklonale antistoffer mot myelomceller.
2007.